Skip to main content
Premium Trial:

Request an Annual Quote

Celera Diagnostics Licenses Luminex xMap Technology

NEW YORK, Aug. 21 - Luminex said today it has given Celera Diagnostics a worldwide exclusive license to develop and distribute in vitro molecular diagnostics products based on Luminex's xMap technology.


Luminex will record as revenue not only the instruments and beads it licenses to Celera Diagnostics but also royalties from any products the Applera unit happens to sell.


Click here for more information.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.